CYPRESS, CA. – Christie will participate in IUVA for the first time and introduce its new UVC disinfection product Christie® CounterAct™ with Ushio Inc.’s patented Care222® technology designed to run continuously with people present while meeting established safety guidelines. The far-UVC 222nm light that Care222 technology emits provides an added layer of defense against pathogens, and it’s the world’s first UVC technology with a proprietary optical filter that blocks potentially harmful UVC wavelengths.
Media welcome to register.
Join us online at IUVA! Meet with our experts to get your questions answered about CounterAct and the power of this exciting new technology. Register now »
About the 2021 IUVA World Congress: Harness the power of UVC light
The 2021 IUVA World Congress promises to bring together worldwide academic and industry participants involved in all aspects of UV. The focus of this online conference is to present the latest and emerging advancements in technology and research addressing the environmental, health, and treatment process challenges of today, as well as to discuss the current trends in ultraviolet regulations and new applications.
